InflaRx (IFRX)
(Delayed Data from NSDQ)
$0.80 USD
-0.01 (-1.83%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $0.80 0.00 (-0.02%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2025
Time: -- |
9/2025 | $-0.19 | 0.00% |
Earnings Summary
For their last quarter, InflaRx (IFRX) reported earnings of -$0.24 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for IFRX's next earnings release expected on November 14, 2025. For the next earning release, we expect the company to report earnings of -$0.19 per share, reflecting a year-over-year increase of 42.42%.
Earnings History
Price & Consensus
Zacks News for IFRX
Axsome Therapeutics (AXSM) Reports Q2 Loss, Beats Revenue Estimates
IFRX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Aligos Therapeutics, Inc. (ALGS) Reports Q1 Loss, Misses Revenue Estimates
InflaRx (IFRX) Loses -15.29% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
InflaRx Stock Rises 8% on Conditional EC Nod for COVID-19 Drug
IFRX FAQs
InflaRx N.V. (IFRX) has announced they will report their next quarter earnings on November 14, 2025. For the next earning release, we expect the company to report earnings of $-0.19 per share, reflecting a year-over-year increase of 42.42%.
InflaRx N.V. has announced they will report their previous quarter earnings after the close of the market on November 14, 2025.
The Zacks Consensus Estimate for InflaRx N.V. (IFRX) for the quarter ending September 2025 is $-0.19 a share. We expect InflaRx N.V. (IFRX) to report earnings in line with the consensus estimate of $-0.19 per share
In the earnings report for the quarter ending in June 2024, InflaRx N.V. (IFRX) announced earnings of $-0.26 per share versus the Zacks Consensus Estimate of $-0.21 per share, representing a surprise of 23.81%.